Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Soaring Growth Stocks That Could Rocket Even Higher

TheMotleyFool

0 0

2 Soaring Growth Stocks That Could Rocket Even Higher: https://g.foolcdn.com/editorial/images/732444/two-people-use-devices-at-home-getty.jpg

So far, 2023 is turning out to be a pretty good year for growth stock investors in general. The Vanguard Growth ETF has already gained 19% in 2023.

For investors with either CRISPR Therapeutics (NASDAQ: CRSP) or Nanox (NASDAQ: NNOX) in their portfolios, it's already been a great year. Shares of both stocks are way up recently. They've risen for straightforward reasons, but there are a few things you should know before trying to ride their momentum higher.

Shares of CRISPR Therapeutics are up more than 57% since the end of 2022. This is still a clinical-stage business that doesn't have any products to sell yet.

Source Fool.com

Like: 0

CRSP

Share